SHANGHAI HEARTCARE MEDICAL TECHNOLO
(HKEX: 6609)
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. Its objective is to redefine the therapeutic and preventive paradigm of stroke. The company was founded by Guo Hui Wang, Kui Ding, and Jia Qi Hong on June 16, 2016 and is headquartered in Shanghai, China.
23.950 -
+0.800
(+3.46%)
Range
22.950 - 23.950
(4.36%)
Open
23.150
Previous Close
23.150
Bid Price
23.200
Bid Volume
('000)
0.3
Ask Price
23.950
Ask Volume
('000)
0.4
Volume
('000)
4.1
Value
95,715
Remark
-
Delayed prices. Updated at 20 Dec 2024 15:59.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
